News Results
There are 122,823 News Results
Nov 2, 2017
Engility Holdings, Inc. (NYSE: EGL) today announced financial results for the third quarter, which ended September 29, 2017.
Nov 5, 2017
DUBLIN, Ohio, Nov. 6, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first-quarter fiscal year 2018 revenues of $32.6 billion, an increase of 2 percent. The company also reported...
Nov 9, 2017
BUENOS AIRES, Nov. 10, 2017 /PRNewswire/ -- -- Consolidated Revenues amounted to P$47,263 million (+21.8% vs. 9M16); Service Revenues reached P$41,646 million (+26.7% vs. 9M16); Fixed Voice Services and Internet...
Nov 14, 2017
Stratasys Ltd . (Nasdaq: SSYS), a global leader in applied additive technology solutions, announced financial results for the third quarter of 2017.
Nov 16, 2017
NEW YORK, Nov. 17, 2017 /PRNewswire/ --
Nov 20, 2017
RARITAN, N.J., Nov. 21, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA)...
Nov 29, 2017
RICHMOND, Va. and SLOUGH, England, Nov. 30, 2017 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved SUBLOCADE(TM) (buprenorphine extended- release)...
Dec 8, 2017
ATLANTA, Dec. 9, 2017 /PRNewswire-USNewswire/ -- In four studies being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers announce promising findings...
Dec 9, 2017
Targeted Therapies Show Promise for Improving Outcomes Across a Spectrum of Hematologic Malignancies
ATLANTA, Dec. 10, 2017 /PRNewswire-USNewswire/ -- Four studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta highlight the multiple ways in...
Dec 9, 2017
EAST HANOVER, N.J., Dec. 10, 2017 /PRNewswire/ -- Novartis today announced updated results from the JULIET clinical trial demonstrating sustained responses with Kymriah(TM) (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019,...
